D-1584-2019 Class III Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1584-2019 was initiated by American Health Packaging on Feb 19, 2019 and is designated Class III. Reason for recall: CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results. The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 14,360 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 14, 2019
Initiation Date
Feb 19, 2019
Termination Date
Sep 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,360 bottles

Product description

Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC 68001-316-08), Rx Only, Manufactured by: Lupin Limited, Goa 403 722 INDIA For BluePoint Laboratories.

Reason for recall

CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.

Distribution pattern

Nationwide within the USA and Puerto Rico

Code information

Lot #: a) G702705 and b) G702706, Exp. 3/31/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1584-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1584-2019. Report a data issue: hello@regdatalab.com.